Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-25 @ 12:36 AM
NCT ID: NCT03656367
Eligibility Criteria: Inclusion Criteria: * Apparently healthy men * 18-40 years of age * Body mass index (BMI): 18.5-24.9 kg/m\^2 * Non-smoker * Haemoglobin concentration ≥8.4 mmol/L Exclusion Criteria: * Dislike for dairy products such as milk, cheese and yoghurt * Weight change \>3 kg 2 months prior to study * Any other blood donation \< 3 month prior to study and during study, than the blood donation that is included in this study * Intensive physical training (\>10 hours of per week) * Self-reported eating disorders or irregular eating schedules (e.g. skipping breakfast) and uncommon diets (vegetarians, vegans etc.) * Alcohol intake above the recommendation from the Danish Health and Medicines Authority (\>21 units of alcohol per week) * Night- or shift work * Food intolerance and allergies related to test products e.g. lactose and gluten * Dietary supplements, if not taken on a regular basis * Currently use, or use within previously 3 months of prescription medication, except non-prescription primary analgetica (NSAID and paracetamol) to relieve e.g. head ache and stomach pain, and glucocorticoider for topical use e.g. in ointment and creams. * Chronic diseases e.g. cancer within the past 5 years (except adequately-treated localized basal cell skin cancer), asthma, back pain, thyroid disease, heart disease, diabetes, inflammation * Disorders: neurological, sleep, diagnosed psychiatric disorder, and gastro intestinal and liver disorders. * Surgical treatment of obesity and abdominal surgery * Inability, physically or mental, to comply with the procedures required by the study protocol as evaluated by the daily study manager, principal investigator or clinical responsible * Subject's general condition contraindicates continuing the study as evaluated by the daily study manager, principal investigator or clinical responsible * Simultaneous participation in other clinical intervention studies
Healthy Volunteers: True
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 40 Years
Study: NCT03656367
Study Brief:
Protocol Section: NCT03656367